Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P.N. Baker is active.

Publication


Featured researches published by P.N. Baker.


British Journal of Obstetrics and Gynaecology | 1991

Platelet angiotensin II binding sites in normotensive and hypertensive women

P.N. Baker; Fiona Broughton Pipkin; E. Malcolm Symonds

Summary. Specific binding of angiotensin II (AII) to platelets was measured in 89 women, 25 nulliparous non‐pregnant women and 64 primigravida in the third trimester of pregnancy. There was significantly lower binding in the 25 pregnant women who were normotensive (2.3 fmol/109 cells) when compared with the non‐pregnant women (9.0 fmol/109 cells P<0.001). Significantly higher platelet AII binding levels were found in the 39 women who had pregnancy induced hypertension (PIH) (5.5 fmol/109 cells) when compared with the 25 normotensive pregnant women (P<0.001). Of the 39 women with PIH, platelet AII binding was higher in the 23 women who had pre‐eclampsia (7.0 fmol/109 cells), when compared with the 16 who had non‐proteinuric PIH, (4.6 fmol/109 cells) although the difference was not statistically significant (P<0.04). The pressor response to AII is also diminished in pregnancy, yet less so if pregnancy induced hypertension develops. Platelets may provide a readily accessible tissue with which to study AII responsiveness in pregnancy.


Hypertension | 1997

Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women

Fiona Broughton Pipkin; P.N. Baker

Studies in anesthetized animals suggest that angiotensin II evokes a depressor as well as a pressor effect, which becomes evident on cessation of infusion. We have studied 18 nonpregnant and 8, 23, and 22 women in the first, second, and third trimesters of pregnancy to determine whether such an effect is present in conscious women, whether it is dose dependent, and whether it is influenced by pregnancy. Angiotensin II was infused intravenously in doubling concentrations at 10-minute intervals until a pressor effect of approximately 20 mm Hg was observed. The infusion was stopped, and blood pressure was monitored at 2-minute intervals for 30 minutes. There was a significant diastolic depressor effect after stopping angiotensin II in the nonpregnant women and those in the second and third trimesters of pregnancy. Individual women required differing doses of angiotensin II to evoke the standardized pressor response. It was thus possible to examine the depressor response in each group in relation to infused doses of angiotensin II. In nonpregnant women and in those in the second and third trimesters of pregnancy, the depressor response was dose dependent (P<.001). At any given dose, the depressor response deepened as pregnancy progressed (P<.001). Basal plasma prostacyclin concentrations rise in pregnancy, and angiotensin II can stimulate prostacyclin synthesis. This might mediate the depressor effect. In conclusion, the diminished pressor response to angiotensin II in normal pregnancy may be partly due to an increasing depressor effect of the hormone.


British Journal of Obstetrics and Gynaecology | 1989

Abdominal pain of unknown aetiology in pregnancy

P.N. Baker; R. J. Madeley; E. M. Symonds

Summary. The outcome of 140 pregnancies complicated by unexplained abdominal pain was compared with that in a comparison group of 280 women who gave birth at the same time. The two groups were comparable for maternal age and parity but the study group contained a significantly higher proportion of smokers, unmarried women, and women whose partners were unemployed (P<0·001). All the pregnancies resulted in livebirths. There were no statistically significant differences in birthweight, gestational age at delivery or mode of delivery between the two groups.


Best Practice & Research in Clinical Obstetrics & Gynaecology | 2000

Angiogenesis and placental growth in normal and compromised pregnancies

Stephen Ong; Gendie E. Lash; P.N. Baker


Clinical Science | 1992

Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension.

P.N. Baker; F. Broughton Pipkin; E. M. Symonds


The Lancet | 1989

ACE INHIBITORS IN PREGNANCY

Naina Mehta; Neena Modi; F. Broughton Pipkin; P.N. Baker; E. M. Symonds


Journal of Medical Genetics | 1998

Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia.

Linda Morgan; Sarah Crawshaw; P.N. Baker; John F. Y. Brookfield; F Broughton Pipkin; Noor Kalsheker


Clinical Science | 1992

Longitudinal study of platelet angiotensin II binding in human pregnancy.

P.N. Baker; Broughton Pipkin F; E. M. Symonds


The Lancet | 1989

PLATELET ANGIOTENSIN II BINDING SITES IN HYPERTENSION IN PREGNANCY

P.N. Baker; F. Broughton Pipkin; E. M. Symonds


American Journal of Obstetrics and Gynecology | 1993

Angiotensin II-induced increases in platelet intracellular free calcium in hypertensive and normotensive pregnancy

P.N. Baker; Mark D. Kilby; F. Broughton Pipkin

Collaboration


Dive into the P.N. Baker's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda Morgan

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Mark D. Kilby

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Neena Modi

Imperial College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge